Literature DB >> 4213416

Systemic mastocytosis: control of lifelong diarrhea by ingested disodium cromoglycate.

J Dolovich, N D Punthakee, A B MacMillan, G J Osbaldeston.   

Abstract

A 16-year-old boy with systemic mastocytosis from birth had a lifelong history of pronounced diarrhea. Treatment with ingested disodium cromoglycate (DSCG) restored a normal bowel movement pattern and this has been maintained for the six months he has been on treatment. Changes in dosage have repeatedly demonstrated a close relationship between the dose of ingested DSCG and the control of the diarrhea. This case report indicates the potential efficacy of ingested DSCG in the treatment of some gastrointestinal disorders.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4213416      PMCID： PMC1947871     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


  14 in total

1.  Disodium chromoglycate in the treatment of allergic bronchial asthma.

Authors:  F Moran; J D Bankier; G Boyd
Journal:  Lancet       Date:  1968-07-20       Impact factor: 79.321

2.  Inhibitory effects of disodium cromoglycate on allergen-inhalation tests.

Authors:  J Pepys; F E Hargreave; M Chan; D S McCarthy
Journal:  Lancet       Date:  1968-07-20       Impact factor: 79.321

3.  Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung.

Authors:  P Sheard; A M Blair
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

4.  The effect of disodium cromoglycate and other inhibitors on in vitro anaphylactic histamine release from guinea pig basophil leucocytes.

Authors:  M W Greaves
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

5.  Clinical trial of disodium cromoglycate in treatment of asthma in children.

Authors:  J M Smith; G F Devey
Journal:  Br Med J       Date:  1968-05-11

6.  Treatment of asthma with disodium cromoglycate (FPL 670, 'Intal').

Authors:  R E Altounyan; J B Howell
Journal:  Respiration       Date:  1969       Impact factor: 3.580

7.  Effect of disodium cromoglycate on exercise-induced asthma.

Authors:  S E Davies
Journal:  Br Med J       Date:  1968-09-07

8.  Mastocytosis and intestinal malabsorption.

Authors:  S A Broitman; R S McCray; J C May; J J Deren; F Ackroyd; L S Gottlieb; W McDermott; N Zamcheck
Journal:  Am J Med       Date:  1970-03       Impact factor: 4.965

9.  Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.

Authors:  J S Cox
Journal:  Nature       Date:  1967-12-30       Impact factor: 49.962

10.  The effect of disodium cromoglycate on nasal provocation tests in children with seasonal allergic rhinitis.

Authors:  I Engström
Journal:  Acta Allergol       Date:  1971-04
View more
  9 in total

Review 1.  Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.

Authors:  Mariana Castells; Dean D Metcalfe; Luis Escribano
Journal:  Am J Clin Dermatol       Date:  2011-08-01       Impact factor: 7.403

2.  Gastrointestinal hemorrhage in mastocytosis.

Authors:  M C Belcon; S M Collins; M F Castelli; A H Qizilbash
Journal:  Can Med Assoc J       Date:  1980-02-09       Impact factor: 8.262

3.  Mastocytosis presenting as a skeletal disorder.

Authors:  J L Delsignore; P M Dvoretsky; D G Hicks; R J O'Keefe; R N Rosier
Journal:  Iowa Orthop J       Date:  1996

4.  Oral and topical sodium cromoglicate in the treatment of diffuse cutaneous mastocytosis in an infant.

Authors:  Alan Martin Edwards; Stepánka Capková
Journal:  BMJ Case Rep       Date:  2011-06-29

Review 5.  Mastocytosis: update on pharmacotherapy and future directions.

Authors:  Juan Carlos Cardet; Cem Akin; Min Jung Lee
Journal:  Expert Opin Pharmacother       Date:  2013-10       Impact factor: 3.889

6.  Oral and inhaled sodium cromoglicate in the management of systemic mastocytosis: a case report.

Authors:  Alan M Edwards; Hans Hagberg
Journal:  J Med Case Rep       Date:  2010-06-26

7.  Near fatal eosinophilic gastroenteritis responding to oral sodium chromoglycate.

Authors:  R J Moots; P Prouse; J M Gumpel
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

Review 8.  Telangiectasia macularis eruptiva perstans: more than skin deep.

Authors:  Casey E Watkins; Winston B Bokor; Stuart Leicht; George Youngberg; Guha Krishnaswamy
Journal:  Dermatol Reports       Date:  2011-07-29

Review 9.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.